301 related articles for article (PubMed ID: 20368546)
1. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF; Ding S; Byrd DR; Cascinelli N; Cochran AJ; Coit DG; Eggermont AM; Johnson T; Kirkwood JM; Leong SP; McMasters KM; Mihm MC; Morton DL; Ross MI; Sondak VK
J Clin Oncol; 2010 May; 28(14):2452-9. PubMed ID: 20368546
[TBL] [Abstract][Full Text] [Related]
2. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.
Ulmer A; Dietz K; Hodak I; Polzer B; Scheitler S; Yildiz M; Czyz Z; Lehnert P; Fehm T; Hafner C; Schanz S; Röcken M; Garbe C; Breuninger H; Fierlbeck G; Klein CA
PLoS Med; 2014 Feb; 11(2):e1001604. PubMed ID: 24558354
[TBL] [Abstract][Full Text] [Related]
4. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion as a prognostic factor in melanoma.
Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
[TBL] [Abstract][Full Text] [Related]
8. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Reintgen DS; Cascinelli N; Urist M; McMasters KM; Ross MI; Kirkwood JM; Atkins MB; Thompson JA; Coit DG; Byrd D; Desmond R; Zhang Y; Liu PY; Lyman GH; Morabito A
J Clin Oncol; 2001 Aug; 19(16):3622-34. PubMed ID: 11504744
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
11. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Morton DL; Hoon DS; Cochran AJ; Turner RR; Essner R; Takeuchi H; Wanek LA; Glass E; Foshag LJ; Hsueh EC; Bilchik AJ; Elashoff D; Elashoff R
Ann Surg; 2003 Oct; 238(4):538-49; discussion 549-50. PubMed ID: 14530725
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.
Buzaid AC; Tinoco LA; Jendiroba D; Tu ZN; Lee JJ; Legha SS; Ross MI; Balch CM; Benjamin RS
J Clin Oncol; 1995 Sep; 13(9):2361-8. PubMed ID: 7666095
[TBL] [Abstract][Full Text] [Related]
15. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
16. S-100B: a stronger prognostic biomarker than LDH in stage IIIB-C melanoma.
Wevers KP; Kruijff S; Speijers MJ; Bastiaannet E; Muller Kobold AC; Hoekstra HJ
Ann Surg Oncol; 2013 Aug; 20(8):2772-9. PubMed ID: 23512078
[TBL] [Abstract][Full Text] [Related]
17. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
20. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
